ALLMedicine™ Bernard-soulier Syndrome Center

Feb 13th, 2023 - Practice Essentials Glanzmann, a Swiss pediatrician, initially described thrombasthenia in 1918 when he noted purpuric bleeding in patients with normal platelet counts.[1] The term thrombasthenia means weak platelets. Glanzmann thrombasthenia (GT)...

Feb 13th, 2023 - Practice Essentials Glanzmann, a Swiss pediatrician, initially described thrombasthenia in 1918 when he noted purpuric bleeding in patients with normal platelet counts. [1] The term thrombasthenia means weak platelets. Glanzmann thrombasthenia (GT...

Feb 13th, 2023 - Practice Essentials Glanzmann, a Swiss pediatrician, initially described thrombasthenia in 1918 when he noted purpuric bleeding in patients with normal platelet counts. [1] The term thrombasthenia means weak platelets. Glanzmann thrombasthenia (GT...

Dec 13th, 2022 - Medication Summary Recombinant factor VIIa (rFVIIa) is approved by the US Food and Drug Administration for the treatment of bleeding in persons with congenital factor VII deficiency, as well as in those with hemophilia A and B with acquired inhibi...

Sep 22nd, 2022 - Bernard-Soulier syndrome (BSS) is a rare congenital bleeding disorder of the platelet, and it is mainly inherited as an autosomal recessive trait. It is caused by both qualitative and quantitative deficiency of the platelet membrane glycoprotein (...

Jan 9th, 2019 - Isolated communities in the Canadian province of Newfoundland and Labrador have an “unusual prevalence” of certain hereditary bleeding disorders, a fact attributable to the province’s unique topography and settlement patterns, according to a new s.